Veracyte
VCYT----
Veracyte (VCYT)
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Veracyte Analyst Rating
View MoreForecast & Rating
Jul 17, 2026Price forecast
$56.55-0.11%
Forecast & RatingBuy
12analysts
- Strong buy66.67%
- Buy16.67%
- Hold8.33%
- Sell8.33%
- Strong sell0.00%
News
- Global Report · 18 hours ago
Fragmented Trading in US Niche Stocks Driven by AI and Diagnostic Catalysts
- benzinga_article · Jul 15 at 05:59 AM
This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
- PUBT · Jul 9 at 03:05 PM
Veracyte to report Q2 results, host conference call
- Tip Ranks · Jul 8 at 08:24 AM
SPCX, AMD, XE – Cathie Wood Bets Millions on SpaceX and XE, Sells AMD Again
- Simplywall · Jul 7 at 10:59 PM
Is Veracyte (VCYT) Fully Valued As Insider Selling And Index Additions Draw Attention?
- PUBT · Jun 22 at 03:31 PM
Veracyte director Karin Eastham disposes of 3,729 common shares worth $197,478.18
